OPC Energy Ltd.
Condensed Consolidated Interim
Financial Statements
As of June 30, 2025
(Unaudited)
|
Page | |
F - 3
|
|
F - 4
|
|
F - 5
|
|
F - 7
|
|
F - 8
|
|
F - 9
|
|
F - 12
|
|
F - 14
|
(1) |
Independent auditors’ review report of August 12, 2025 on the Company’s Condensed Consolidated Financial Information as of June 30, 2025 and for the six-and three-month periods then ended.
|
(2) |
Independent auditors’ special report of August 12, 2025 on the Company’s separate interim financial information as of June 30, 2025, in accordance with Regulation 38D to the Securities Regulations (Periodic and Immediate Reports), 1970
and for the six- and three-month periods then ended.
|
June 30
|
June 30
|
December 31
|
||||||||||
2025
|
2024
|
2024
|
||||||||||
(Unaudited)
|
(Unaudited)
|
(Audited)
|
||||||||||
NIS million
|
NIS million
|
NIS million
|
||||||||||
Current assets
|
||||||||||||
Cash and cash equivalents
|
1,586
|
722
|
962
|
|||||||||
Trade receivables
|
408
|
360
|
293
|
|||||||||
Other receivables and debit balances
|
72
|
383
|
90
|
|||||||||
Total current assets
|
2,066
|
1,465
|
1,345
|
|||||||||
Non‑current assets
|
||||||||||||
Long-term restricted deposits and cash
|
54
|
58
|
60
|
|||||||||
Long-term receivables and debit balances
|
153
|
221
|
162
|
|||||||||
Investments in associates
|
5,289
|
2,661
|
5,320
|
|||||||||
Long-term derivative financial instruments
|
40
|
60
|
44
|
|||||||||
Property, plant & equipment
|
4,204
|
6,680
|
4,238
|
|||||||||
Right‑of‑use assets and deferred expenses
|
648
|
622
|
637
|
|||||||||
Intangible assets
|
264
|
1,168
|
261
|
|||||||||
Total non‑current assets
|
10,652
|
11,470
|
10,722
|
|||||||||
Total assets
|
12,718
|
12,935
|
12,067
|
June 30
|
June 30
|
December 31
|
||||||||||
2025
|
2024
|
2024
|
||||||||||
(Unaudited)
|
(Unaudited)
|
(Audited)
|
||||||||||
NIS million
|
NIS million
|
NIS million
|
||||||||||
Current liabilities
|
||||||||||||
Loans and credit from banking corporations and financial institutions (including current maturities)
|
93
|
146
|
82
|
|||||||||
Current maturities of debt from non‑controlling interests
|
13
|
29
|
14
|
|||||||||
Current maturities of debentures
|
236
|
202
|
212
|
|||||||||
Trade payables
|
321
|
319
|
213
|
|||||||||
Payables and credit balances
|
245
|
445
|
123
|
|||||||||
Total current liabilities
|
908
|
1,141
|
644
|
|||||||||
Non‑current liabilities
|
||||||||||||
Long-term loans from banking corporations and financial institutions
|
2,401
|
2,880
|
2,150
|
|||||||||
Long-term debt from non-controlling interests
|
444
|
469
|
500
|
|||||||||
Debentures
|
1,546
|
1,756
|
1,663
|
|||||||||
Long-term lease liabilities
|
26
|
201
|
31
|
|||||||||
Long-term derivative financial instruments
|
-
|
45
|
-
|
|||||||||
Other long‑term liabilities
|
11
|
567
|
115
|
|||||||||
Deferred tax liabilities
|
513
|
495
|
543
|
|||||||||
Total non-current liabilities
|
4,941
|
6,413
|
5,002
|
|||||||||
Total liabilities
|
5,849
|
7,554
|
5,646
|
|||||||||
Equity
|
||||||||||||
Share capital
|
3
|
2
|
3
|
|||||||||
Share premium
|
4,842
|
3,211
|
3,993
|
|||||||||
Capital reserves
|
135
|
619
|
532
|
|||||||||
Retained earnings
|
295
|
115
|
224
|
|||||||||
Total equity attributable to the Company’s shareholders
|
5,275
|
3,947
|
4,752
|
|||||||||
Non‑controlling interests
|
1,594
|
1,434
|
1,669
|
|||||||||
Total equity
|
6,869
|
5,381
|
6,421
|
|||||||||
Total liabilities and equity
|
12,718
|
12,935
|
12,067
|
Yair Caspi
|
Giora Almogy
|
Shai Abramovitz
|
||
Chairman of the Board of Directors
|
CEO
|
Chief Comptroller1
|
For the six-month period
ended June 30
|
For the three-month period
ended June 30
|
For the year ended
December 31
|
||||||||||||||||||
2025
|
2024
|
2025
|
2024
|
2024
|
||||||||||||||||
(Unaudited)
|
(Unaudited)
|
(Unaudited)
|
(Unaudited)
|
(Audited)
|
||||||||||||||||
NIS million
|
NIS million
|
NIS million
|
NIS million
|
NIS million
|
||||||||||||||||
Revenues from sales and provision of services
|
1,361
|
1,311
|
701
|
673
|
2,779
|
|||||||||||||||
Cost of sales and services (excluding depreciation and amortization)
|
(1,040
|
)
|
(911
|
)
|
(539
|
)
|
(481
|
)
|
(1,931
|
)
|
||||||||||
Depreciation and amortization
|
(121
|
)
|
(155
|
)
|
(59
|
)
|
(81
|
)
|
(317
|
)
|
||||||||||
Gross income
|
200
|
245
|
103
|
111
|
531
|
|||||||||||||||
Share in profits of associates
|
212
|
86
|
74
|
14
|
166
|
|||||||||||||||
Compensation for loss of income
|
-
|
26
|
-
|
-
|
44
|
|||||||||||||||
General and administrative expenses
|
(148
|
)
|
(119
|
)
|
(94
|
)
|
(58
|
)
|
(263
|
)
|
||||||||||
Business development expenses
|
(6
|
)
|
(22
|
)
|
(3
|
)
|
(10
|
)
|
(45
|
)
|
||||||||||
Gain on loss of control in the US Renewable Energy Segment
|
-
|
-
|
-
|
-
|
259
|
|||||||||||||||
Other revenues (expenses), net
|
(16
|
)
|
(52
|
)
|
(5
|
)
|
4
|
(56
|
)
|
|||||||||||
Operating profit
|
242
|
164
|
75
|
61
|
636
|
|||||||||||||||
Finance expenses
|
(142
|
)
|
(172
|
)
|
(83
|
)
|
(96
|
)
|
(339
|
)
|
||||||||||
Finance income
|
23
|
23
|
11
|
8
|
87
|
|||||||||||||||
Loss from extinguishment of financial liabilities
|
-
|
-
|
-
|
-
|
(49
|
)
|
||||||||||||||
Finance expenses, net
|
(119
|
)
|
(149
|
)
|
(72
|
)
|
(88
|
)
|
(301
|
)
|
||||||||||
Profit (loss) before taxes on income
|
123
|
15
|
3
|
(27
|
)
|
335
|
||||||||||||||
Expenses for income tax
|
(26
|
)
|
(27
|
)
|
1
|
-
|
(138
|
)
|
||||||||||||
Profit (loss) for the period
|
97
|
(12
|
)
|
4
|
(27
|
)
|
197
|
|||||||||||||
Attributable to:
|
||||||||||||||||||||
The Company’s shareholders
|
71
|
2
|
5
|
(16
|
)
|
111
|
||||||||||||||
Non‑controlling interests
|
26
|
(14
|
)
|
(1
|
)
|
(11
|
)
|
86
|
||||||||||||
Profit (loss) for the period
|
97
|
(12
|
)
|
4
|
(27
|
)
|
197
|
|||||||||||||
Earnings (loss) per share attributable to the Company’s owners
|
||||||||||||||||||||
Basic and diluted earnings (loss) per share (in NIS)
|
0.28
|
0.01
|
0.02
|
(0.07
|
)
|
0.46
|
For the six-month period
ended June 30
|
For the three-month period
ended June 30
|
For the year ended
December 31
|
||||||||||||||||||
2025
|
2024
|
2025
|
2024
|
2024
|
||||||||||||||||
(Unaudited)
|
(Unaudited)
|
(Unaudited)
|
(Unaudited)
|
(Audited)
|
||||||||||||||||
NIS million
|
NIS million
|
NIS million
|
NIS million
|
NIS million
|
||||||||||||||||
Profit (loss) for the period
|
97
|
(12
|
)
|
4
|
(27
|
)
|
197
|
|||||||||||||
Components of other
comprehensive income (loss) which, after being recognized in comprehensive income were or will be carried to profit and loss
|
||||||||||||||||||||
Effective portion of the change in the fair value of cash flow hedges
|
(5
|
)
|
25
|
(1
|
)
|
7
|
42
|
|||||||||||||
Net change in fair value of derivative financial instruments used to hedge cash flows transferred to profit and loss
|
(2
|
)
|
(8
|
)
|
(2
|
)
|
(6
|
)
|
(11
|
)
|
||||||||||
Group’s share in other comprehensive income (loss) of associates, net of tax
|
(93
|
)
|
(56
|
)
|
(33
|
)
|
5
|
13
|
||||||||||||
Foreign currency translation differences in respect of foreign operations
|
(*)(432)
|
|
159
|
(*)(541
|
)
|
94
|
(8
|
)
|
||||||||||||
Tax on other comprehensive income items
|
29
|
(7
|
)
|
35
|
(3
|
)
|
(6
|
)
|
||||||||||||
Other comprehensive income (loss)
for the period, net of tax
|
(503
|
)
|
113
|
(542
|
)
|
97
|
30
|
|||||||||||||
Total comprehensive income (loss)
for the period
|
(406
|
)
|
101
|
(538
|
)
|
70
|
227
|
|||||||||||||
Attributable to:
|
||||||||||||||||||||
The Company’s shareholders
|
(304
|
)
|
95
|
(408
|
)
|
58
|
121
|
|||||||||||||
Non‑controlling interests
|
(102
|
)
|
6
|
(130
|
)
|
12
|
106
|
|||||||||||||
Comprehensive income (loss) for
the period
|
(406
|
)
|
101
|
(538
|
)
|
70
|
227
|
Attributable to the Company’s shareholders
|
||||||||||||||||||||||||||||||||||||
Share capital
|
Share premium
|
Capital reserves
|
Hedge fund
|
Foreign operations translation reserve
|
Retained earnings
|
Total
|
Non‑controlling interests
|
Total equity
|
||||||||||||||||||||||||||||
NIS million
|
NIS million
|
NIS million
|
NIS million
|
NIS million
|
NIS million
|
NIS million
|
NIS million
|
NIS million
|
||||||||||||||||||||||||||||
(Unaudited)
|
||||||||||||||||||||||||||||||||||||
For the six-month period ended June 30, 2025
|
||||||||||||||||||||||||||||||||||||
Balance as of January 1, 2025
|
3
|
3,993
|
247
|
49
|
236
|
224
|
4,752
|
1,669
|
6,421
|
|||||||||||||||||||||||||||
Issuance of shares (less issuance expenses)
|
*-
|
826
|
-
|
-
|
-
|
-
|
826
|
-
|
826
|
|||||||||||||||||||||||||||
Investments by holders of non-controlling interests in equity of subsidiary
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
35
|
35
|
|||||||||||||||||||||||||||
Share-based payment
|
-
|
-
|
2
|
-
|
-
|
-
|
2
|
-
|
2
|
|||||||||||||||||||||||||||
Exercised and expired options and RSUs
|
*-
|
23
|
(23
|
)
|
-
|
-
|
-
|
-
|
-
|
-
|
||||||||||||||||||||||||||
Dividend paid to non‑controlling interests
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
(9
|
)
|
(9
|
)
|
|||||||||||||||||||||||||
Other
|
-
|
-
|
(1
|
)
|
-
|
-
|
-
|
(1
|
)
|
1
|
-
|
|||||||||||||||||||||||||
Other comprehensive loss for the period, net of tax
|
-
|
-
|
-
|
(66
|
)
|
(309
|
)
|
-
|
(375
|
)
|
(128
|
)
|
(503
|
)
|
||||||||||||||||||||||
Profit for the period
|
-
|
-
|
-
|
-
|
-
|
71
|
71
|
26
|
97
|
|||||||||||||||||||||||||||
Balance as of June 30, 2025
|
3
|
4,842
|
225
|
(17
|
)
|
(73
|
)
|
295
|
5,275
|
1,594
|
6,869
|
|||||||||||||||||||||||||
For the six-month period ended June 30, 2024
|
||||||||||||||||||||||||||||||||||||
Balance as of January 1, 2024
|
2
|
3,210
|
248
|
25
|
250
|
113
|
3,848
|
1,394
|
5,242
|
|||||||||||||||||||||||||||
Investments by holders of non-controlling interests in equity of subsidiary
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
34
|
34
|
|||||||||||||||||||||||||||
Share-based payment
|
-
|
-
|
4
|
-
|
-
|
-
|
4
|
-
|
4
|
|||||||||||||||||||||||||||
Exercised options and RSUs
|
*-
|
1
|
(1
|
)
|
-
|
-
|
-
|
-
|
-
|
-
|
||||||||||||||||||||||||||
Other comprehensive income (loss) for the period, net of tax
|
-
|
-
|
-
|
(27
|
)
|
120
|
-
|
93
|
20
|
113
|
||||||||||||||||||||||||||
Profit (loss) for the period
|
-
|
-
|
-
|
-
|
-
|
2
|
2
|
(14
|
)
|
(12
|
)
|
|||||||||||||||||||||||||
Balance as of June 30, 2024
|
2
|
3,211
|
251
|
(2
|
)
|
370
|
115
|
3,947
|
1,434
|
5,381
|
Attributable to the Company’s shareholders
|
||||||||||||||||||||||||||||||||||||
Share capital
|
Share premium
|
Capital reserves
|
Hedge fund
|
Foreign operations translation reserve
|
Retained earnings
|
Total
|
Non‑controlling interests
|
Total equity
|
||||||||||||||||||||||||||||
NIS million
|
NIS million
|
NIS million
|
NIS million
|
NIS million
|
NIS million
|
NIS million
|
NIS million
|
NIS million
|
||||||||||||||||||||||||||||
(Unaudited)
|
||||||||||||||||||||||||||||||||||||
For the three-month period ended June 30, 2025
|
||||||||||||||||||||||||||||||||||||
Balance as of April 1, 2025
|
3
|
3,997
|
244
|
8
|
315
|
290
|
4,857
|
1,714
|
6,571
|
|||||||||||||||||||||||||||
Issuance of shares (less issuance expenses)
|
*-
|
826
|
-
|
-
|
-
|
-
|
826
|
-
|
826
|
|||||||||||||||||||||||||||
Investments by holders of non-controlling interests in equity of subsidiary
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
19
|
19
|
|||||||||||||||||||||||||||
Share-based payment
|
-
|
-
|
1
|
-
|
-
|
-
|
1
|
-
|
1
|
|||||||||||||||||||||||||||
Exercised and expired options and RSUs
|
*-
|
19
|
(19
|
)
|
-
|
-
|
-
|
-
|
-
|
-
|
||||||||||||||||||||||||||
Dividend paid to non‑controlling interests
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
(9
|
)
|
(9
|
)
|
|||||||||||||||||||||||||
Other
|
-
|
-
|
(1
|
)
|
-
|
-
|
-
|
(1
|
)
|
-
|
(1
|
)
|
||||||||||||||||||||||||
Other comprehensive income (loss) for the period, net of tax
|
-
|
-
|
-
|
(25
|
)
|
(388
|
)
|
-
|
(413
|
)
|
(129
|
)
|
(542
|
)
|
||||||||||||||||||||||
Profit (loss) for the period
|
-
|
-
|
-
|
-
|
-
|
5
|
5
|
(1
|
)
|
4
|
||||||||||||||||||||||||||
Balance as of June 30, 2025
|
3
|
4,842
|
225
|
(17
|
)
|
(73
|
)
|
295
|
5,275
|
1,594
|
6,869
|
|||||||||||||||||||||||||
For the three-month period ended June 30, 2024
|
||||||||||||||||||||||||||||||||||||
Balance as of April 1, 2024
|
2
|
3,210
|
249
|
(5
|
)
|
299
|
131
|
3,886
|
1,388
|
5,274
|
||||||||||||||||||||||||||
Investments by holders of non-controlling interests in equity of subsidiary
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
34
|
34
|
|||||||||||||||||||||||||||
Share-based payment
|
-
|
-
|
3
|
-
|
-
|
-
|
3
|
-
|
3
|
|||||||||||||||||||||||||||
Exercised options and RSUs
|
*-
|
1
|
(1
|
)
|
-
|
-
|
-
|
-
|
-
|
-
|
||||||||||||||||||||||||||
Other comprehensive income for the period, net of tax
|
-
|
-
|
-
|
3
|
71
|
-
|
74
|
23
|
97
|
|||||||||||||||||||||||||||
Loss for the period
|
-
|
-
|
-
|
-
|
-
|
(16
|
)
|
(16
|
)
|
(11
|
)
|
(27
|
)
|
|||||||||||||||||||||||
Balance as of June 30, 2024
|
2
|
3,211
|
251
|
(2
|
)
|
370
|
115
|
3,947
|
1,434
|
5,381
|
Attributable to the Company’s shareholders
|
||||||||||||||||||||||||||||||||||||
Share capital
|
Share premium
|
Capital reserves
|
Hedge fund
|
Foreign operations translation reserve
|
Retained earnings
|
Total
|
Non‑controlling interests
|
Total equity
|
||||||||||||||||||||||||||||
NIS million
|
NIS million
|
NIS million
|
NIS million
|
NIS million
|
NIS million
|
NIS million
|
NIS million
|
NIS million
|
||||||||||||||||||||||||||||
(Audited)
|
||||||||||||||||||||||||||||||||||||
For the year ended December 31, 2024
|
||||||||||||||||||||||||||||||||||||
Balance as of January 1, 2024
|
2
|
3,210
|
248
|
25
|
250
|
113
|
3,848
|
1,394
|
5,242
|
|||||||||||||||||||||||||||
Issuance of shares (less issuance expenses)
|
1
|
779
|
-
|
-
|
-
|
-
|
780
|
-
|
780
|
|||||||||||||||||||||||||||
Investments by holders of non-controlling interests in equity of subsidiary
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
175
|
175
|
|||||||||||||||||||||||||||
Share-based payment
|
-
|
-
|
7
|
-
|
-
|
-
|
7
|
1
|
8
|
|||||||||||||||||||||||||||
Exercised and expired options and RSUs
|
*-
|
4
|
(4
|
)
|
-
|
-
|
-
|
-
|
-
|
-
|
||||||||||||||||||||||||||
Other
|
-
|
-
|
(4
|
)
|
-
|
-
|
-
|
(4
|
)
|
(7
|
)
|
(11
|
)
|
|||||||||||||||||||||||
Other comprehensive income for the year, net of tax
|
-
|
-
|
-
|
24
|
(14
|
)
|
-
|
10
|
20
|
30
|
||||||||||||||||||||||||||
Profit for the year
|
-
|
-
|
-
|
-
|
-
|
111
|
111
|
86
|
197
|
|||||||||||||||||||||||||||
Balance as of December 31, 2024
|
3
|
3,993
|
247
|
49
|
236
|
224
|
4,752
|
1,669
|
6,421
|
For the six-month period
ended June 30
|
For the three-month period
ended June 30
|
For the year ended
December 31
|
||||||||||||||||||
2025
|
2024
|
2025
|
2024
|
2024
|
||||||||||||||||
(Unaudited)
|
(Unaudited)
|
(Unaudited)
|
(Unaudited)
|
(Audited)
|
||||||||||||||||
NIS million
|
NIS million
|
NIS million
|
NIS million
|
NIS million
|
||||||||||||||||
Cash flows from operating activities
|
||||||||||||||||||||
Profit (loss) for the period
|
97
|
(12
|
)
|
4
|
(27
|
)
|
197
|
|||||||||||||
Adjustments:
|
||||||||||||||||||||
Depreciation and amortization
|
129
|
162
|
63
|
85
|
333
|
|||||||||||||||
Diesel fuel consumption
|
16
|
8
|
12
|
4
|
12
|
|||||||||||||||
Finance expenses, net
|
119
|
149
|
72
|
88
|
301
|
|||||||||||||||
Expenses (income) for income tax
|
26
|
27
|
(1
|
)
|
-
|
138
|
||||||||||||||
Share in profits of associates
|
(212
|
)
|
(86
|
)
|
(74
|
)
|
(14
|
)
|
(166
|
)
|
||||||||||
Other expenses (revenues), net
|
16
|
52
|
5
|
(4
|
)
|
56
|
||||||||||||||
Gain on loss of control in the US Renewable Energy Segment
|
-
|
-
|
-
|
-
|
(259
|
)
|
||||||||||||||
Share-based payment transactions
|
39
|
10
|
40
|
4
|
35
|
|||||||||||||||
230
|
310
|
121
|
136
|
647
|
||||||||||||||||
Changes in trade and other receivables
|
(130
|
)
|
(101
|
)
|
(148
|
)
|
(140
|
)
|
(64
|
)
|
||||||||||
Changes in trade payables, service providers, payables and other long-term liabilities
|
123
|
96
|
76
|
64
|
14
|
|||||||||||||||
(7
|
)
|
(5
|
)
|
(72
|
)
|
(76
|
)
|
(50
|
)
|
|||||||||||
Dividends received from associates
|
95
|
26
|
36
|
8
|
235
|
|||||||||||||||
Income taxes paid
|
-
|
(4
|
)
|
-
|
(4
|
)
|
(67
|
)
|
||||||||||||
Net cash provided by operating activities
|
318
|
327
|
85
|
64
|
765
|
|||||||||||||||
Cash flows used in investing activities
|
||||||||||||||||||||
Interest received
|
16
|
12
|
5
|
5
|
35
|
|||||||||||||||
Investment in associates (see Note 10)
|
(395
|
)
|
(28
|
)
|
(117
|
)
|
(18
|
)
|
(737
|
)
|
||||||||||
Purchase of property, plant, and equipment, intangible assets and deferred expenses
|
(138
|
)
|
(505
|
)
|
(90
|
)
|
(251
|
)
|
(1,260
|
)
|
||||||||||
Loss of control in the US Renewable Energies Segment
|
-
|
-
|
-
|
-
|
134
|
|||||||||||||||
Proceeds for repayment of partnership capital from associates
|
3
|
-
|
3
|
-
|
95
|
|||||||||||||||
Other
|
11
|
7
|
10
|
(3
|
)
|
21
|
||||||||||||||
Net cash used for investing activities
|
(503
|
)
|
(514
|
)
|
(189
|
)
|
(267
|
)
|
(1,712
|
)
|
For the six-month period
ended June 30
|
For the three-month period
ended June 30
|
For the year ended
December 31
|
||||||||||||||||||
2025
|
2024
|
2025
|
2024
|
2024
|
||||||||||||||||
(Unaudited)
|
(Unaudited)
|
(Unaudited)
|
(Unaudited)
|
(Audited)
|
||||||||||||||||
NIS million
|
NIS million
|
NIS million
|
NIS million
|
NIS million
|
||||||||||||||||
Cash flows provided by financing activities
|
||||||||||||||||||||
Proceeds of share issuance, less issuance expenses
|
826
|
-
|
826
|
-
|
780
|
|||||||||||||||
Proceeds of debenture issuance, less issuance expenses
|
-
|
198
|
-
|
-
|
198
|
|||||||||||||||
Receipt of long-term loans from banking corporations and financial institutions, net
|
300
|
35
|
150
|
2
|
1,951
|
|||||||||||||||
Receipt of long-term debt from non-controlling interests
|
11
|
24
|
6
|
11
|
104
|
|||||||||||||||
Investments by holders of non-controlling interests in equity of subsidiary
|
35
|
34
|
19
|
34
|
175
|
|||||||||||||||
Change in short term loans from banking corporations, net
|
(2
|
)
|
(205
|
)
|
-
|
(2
|
)
|
(204
|
)
|
|||||||||||
Tax equity partner’s investment in US-based renewable energy projects
|
-
|
152
|
-
|
152
|
152
|
|||||||||||||||
Interest paid
|
(90
|
)
|
(119
|
)
|
(32
|
)
|
(53
|
)
|
(228
|
)
|
||||||||||
Dividend paid to non‑controlling interests
|
(9
|
)
|
-
|
(9
|
)
|
-
|
-
|
|||||||||||||
Repayment of long-term loans from banking corporations and others
|
(43
|
)
|
(126
|
)
|
(21
|
)
|
(64
|
)
|
(1,755
|
)
|
||||||||||
Repayment of long-term loans from non-controlling interests
|
(49
|
)
|
(9
|
)
|
(20
|
)
|
-
|
(76
|
)
|
|||||||||||
Repayment of debentures
|
(106
|
)
|
(96
|
)
|
-
|
-
|
(193
|
)
|
||||||||||||
Other
|
14
|
(7
|
)
|
16
|
(2
|
)
|
(13
|
)
|
||||||||||||
Net cash provided by (used for) financing activities
|
887
|
(119
|
)
|
935
|
78
|
891
|
||||||||||||||
Net increase (decrease) in cash and cash equivalents
|
702
|
(306
|
)
|
831
|
(125
|
)
|
(56
|
)
|
||||||||||||
Balance of cash and cash equivalents as of the beginning of the period
|
962
|
1,007
|
837
|
838
|
1,007
|
|||||||||||||||
Effect of exchange rate fluctuations on cash and cash equivalent balances
|
(78
|
)
|
21
|
(82
|
)
|
9
|
11
|
|||||||||||||
Balance of cash and cash equivalents as of the end of the period
|
1,586
|
722
|
1,586
|
722
|
962
|
A. |
Statement of compliance with International Financial Reporting Standards (IFRS)
|
B. |
Functional and presentation currency
|
C. |
Use of estimates and judgments
|
D. |
Seasonality
|
For the six-month period ended June 30, 2025
|
||||||||||||||||||||||||
Israel
|
US Energy Transition Segment
|
US Renewable Energies
|
Other activities in the US
|
Adjustments to consolidated
|
Consolidated – total
|
|||||||||||||||||||
In NIS million
|
(Unaudited)
|
|||||||||||||||||||||||
Revenues from sales and provision of services
|
1,075
|
1,395
|
89
|
194
|
(1,392
|
)
|
1,361
|
|||||||||||||||||
EBITDA after proportionate consolidation
|
264
|
498
|
59
|
(7
|
)
|
(557
|
)
|
257
|
||||||||||||||||
Adjustments:
|
||||||||||||||||||||||||
Share in profits of associates
|
212
|
|||||||||||||||||||||||
General and administrative expenses at the US headquarters (not attributed to US segments)
|
(71
|
)
|
||||||||||||||||||||||
General and administrative expenses at the Company’s headquarters (not attributed to the operating segments)
|
(11
|
)
|
||||||||||||||||||||||
Total EBITDA
|
387
|
|||||||||||||||||||||||
Depreciation and amortization
|
(129
|
)
|
||||||||||||||||||||||
Finance expenses, net
|
(119
|
)
|
||||||||||||||||||||||
Other expenses, net
|
(16
|
)
|
||||||||||||||||||||||
(264
|
)
|
|||||||||||||||||||||||
Profit before taxes on income
|
123
|
|||||||||||||||||||||||
Expenses for income tax
|
(26
|
)
|
||||||||||||||||||||||
Profit for the period
|
97
|
For the six-month period ended June 30, 2024
|
||||||||||||||||||||||||
Israel
|
US Energy Transition Segment
|
US Renewable Energies
|
Other activities in the US
|
Adjustments to consolidated
|
Consolidated – total
|
|||||||||||||||||||
In NIS million
|
(Unaudited)
|
|||||||||||||||||||||||
Revenues from sales and provision of services
|
1,074
|
880
|
139
|
47
|
(829
|
)
|
1,311
|
|||||||||||||||||
EBITDA after proportionate consolidation
|
286
|
278
|
63
|
(14
|
)
|
(281
|
)
|
332
|
||||||||||||||||
Adjustments:
|
||||||||||||||||||||||||
Share in profits of associates
|
86
|
|||||||||||||||||||||||
General and administrative expenses at the US headquarters (not attributed to US segments)
|
(32
|
)
|
||||||||||||||||||||||
General and administrative expenses at the Company’s headquarters (not attributed to the operating segments)
|
(8
|
)
|
||||||||||||||||||||||
Total EBITDA
|
378
|
|||||||||||||||||||||||
Depreciation and amortization
|
(162
|
)
|
||||||||||||||||||||||
Finance expenses, net
|
(149
|
)
|
||||||||||||||||||||||
Other expenses, net
|
(52
|
)
|
||||||||||||||||||||||
(363
|
)
|
|||||||||||||||||||||||
Profit before taxes on income
|
15
|
|||||||||||||||||||||||
Expenses for income tax
|
(27
|
)
|
||||||||||||||||||||||
Loss for the period
|
(12
|
)
|
1 |
For a definition of EBITDA following proportionate consolidation, see Note 25 to the Annual Financial Statements.
|
For the three-month period ended June 30, 2025
|
||||||||||||||||||||||||
Israel
|
US Energy Transition Segment
|
US Renewable Energies
|
Other activities in the US
|
Adjustments to consolidated
|
Consolidated – total
|
|||||||||||||||||||
In NIS million
|
(Unaudited)
|
|||||||||||||||||||||||
Revenues from sales and provision of services
|
549
|
616
|
44
|
105
|
(613
|
)
|
701
|
|||||||||||||||||
EBITDA after proportionate consolidation
|
127
|
221
|
32
|
1
|
(253
|
)
|
128
|
|||||||||||||||||
Adjustments:
|
||||||||||||||||||||||||
Share in profits of associates
|
74
|
|||||||||||||||||||||||
General and administrative expenses at the US headquarters (not attributed to segments)
|
(54
|
)
|
||||||||||||||||||||||
General and administrative expenses at the Company’s headquarters (not attributed to segments)
|
(5
|
)
|
||||||||||||||||||||||
Total EBITDA
|
143
|
|||||||||||||||||||||||
Depreciation and amortization
|
(63
|
)
|
||||||||||||||||||||||
Finance expenses, net
|
(72
|
)
|
||||||||||||||||||||||
Other expenses, net
|
(5
|
)
|
||||||||||||||||||||||
(140
|
)
|
|||||||||||||||||||||||
Profit before taxes on income
|
3
|
|||||||||||||||||||||||
Tax benefit
|
1
|
|||||||||||||||||||||||
Profit for the period
|
4
|
For the three-month period ended June 30, 2024
|
||||||||||||||||||||||||
Israel
|
US Energy Transition Segment
|
US Renewable Energies
|
Other activities in the US
|
Adjustments to consolidated
|
Consolidated – total
|
|||||||||||||||||||
In NIS million
|
(Unaudited)
|
|||||||||||||||||||||||
Revenues from sales and provision of services
|
542
|
362
|
79
|
26
|
(336
|
)
|
673
|
|||||||||||||||||
EBITDA after proportionate consolidation
|
116
|
112
|
35
|
(5
|
)
|
(113
|
)
|
145
|
||||||||||||||||
Adjustments:
|
||||||||||||||||||||||||
Share in profits of associates
|
14
|
|||||||||||||||||||||||
General and administrative expenses at the US headquarters (not attributed to US segments)
|
(12
|
)
|
||||||||||||||||||||||
General and administrative expenses at the Company’s headquarters (not attributed to the operating segments)
|
(5
|
)
|
||||||||||||||||||||||
Total EBITDA
|
142
|
|||||||||||||||||||||||
Depreciation and amortization
|
(85
|
)
|
||||||||||||||||||||||
Finance expenses, net
|
(88
|
)
|
||||||||||||||||||||||
Other revenues, net
|
4
|
|||||||||||||||||||||||
(169
|
)
|
|||||||||||||||||||||||
Loss before income taxes
|
(27
|
)
|
||||||||||||||||||||||
Expenses for income tax
|
-
|
|||||||||||||||||||||||
Loss for the period
|
(27
|
)
|
For the year ended December 31, 2024
|
||||||||||||||||||||||||
Israel
|
US Energy Transition Segment
|
US Renewable Energies
|
Other activities in the US
|
Adjustments to consolidated
|
Consolidated – total
|
|||||||||||||||||||
In NIS million
|
(Audited)
|
|||||||||||||||||||||||
Revenues from sales and provision of services
|
2,312
|
1,796
|
228
|
145
|
(1,702
|
)
|
2,779
|
|||||||||||||||||
EBITDA after proportionate consolidation
|
639
|
588
|
112
|
(22
|
)
|
(608
|
)
|
709
|
||||||||||||||||
Adjustments:
|
||||||||||||||||||||||||
Share in profits of associates
|
166
|
|||||||||||||||||||||||
General and administrative expenses at the US headquarters (not attributed to US segments)
|
(89
|
)
|
||||||||||||||||||||||
General and administrative expenses at the Company’s headquarters (not attributed to the operating segments)
|
(20
|
)
|
||||||||||||||||||||||
Total EBITDA
|
766
|
|||||||||||||||||||||||
Depreciation and amortization
|
(333
|
)
|
||||||||||||||||||||||
Finance expenses, net
|
(301
|
)
|
||||||||||||||||||||||
Gain on loss of control in the US Renewable Energy Segment
|
259
|
|||||||||||||||||||||||
Other expenses, net
|
(56
|
)
|
||||||||||||||||||||||
(431
|
)
|
|||||||||||||||||||||||
Profit before taxes on income
|
335
|
|||||||||||||||||||||||
Expenses for income tax
|
(138
|
)
|
||||||||||||||||||||||
Profit for the year
|
197
|
For the six-month period
ended June 30
|
For the three-month period
ended June 30
|
For the year ended December 31
|
||||||||||||||||||
2025
|
2024
|
2025
|
2024
|
2024
|
||||||||||||||||
In NIS million
|
(Unaudited)
|
(Unaudited)
|
(Audited)
|
|||||||||||||||||
Revenues from sale of electricity in Israel:
|
||||||||||||||||||||
Revenues from the sale of energy to private customers
|
559
|
605
|
277
|
305
|
1,368
|
|||||||||||||||
Revenues from energy sales to the System Operator and other suppliers
|
104
|
96
|
54
|
50
|
165
|
|||||||||||||||
Revenues for capacity services
|
70
|
88
|
37
|
46
|
171
|
|||||||||||||||
Revenues from the sale of energy to the System Operator, at cogeneration tariff
|
49
|
25
|
31
|
6
|
83
|
|||||||||||||||
Revenues from sale of steam in Israel
|
31
|
30
|
16
|
13
|
57
|
|||||||||||||||
Other revenues in Israel
|
-
|
23
|
-
|
16
|
23
|
|||||||||||||||
Total revenues from sale of energy and others in Israel (excluding infrastructure services)
|
813
|
867
|
415
|
436
|
1,867
|
|||||||||||||||
Revenues from private customers for infrastructure services
|
262
|
207
|
134
|
106
|
445
|
|||||||||||||||
Total revenues in Israel
|
1,075
|
1,074
|
549
|
542
|
2,312
|
|||||||||||||||
Revenues from sale of electricity from renewable energy (*)
|
-
|
125
|
-
|
69
|
195
|
|||||||||||||||
Revenues from sale of retail electricity and others
|
286
|
112
|
152
|
62
|
272
|
|||||||||||||||
Total revenues in the US
|
286
|
237
|
152
|
131
|
467
|
|||||||||||||||
Total revenues
|
1,361
|
1,311
|
701
|
673
|
2,779
|
A. |
Significant events during and subsequent to the Reporting Period
|
1. |
Banking financing agreements in OPC Israel
|
2. |
Short-term credit facilities:
|
Facility amount
|
Utilization as of the report date (1)
|
|||||||
The Company
|
300
|
-
|
||||||
OPC Israel
|
300
|
2
|
||||||
The Company for CPV Group (2)
|
Approx. 167 (USD 20 million and NIS 100 million) |
34
|
||||||
CPV Group(2)
|
Approx. 253 (USD 75 million(3)) |
185
|
||||||
Total
|
1,020
|
221
|
(1) |
Mostly for the purpose of letters of credit and bank guarantees.
|
(2) |
The facilities provided to the CPV Group or for the CPV Group, which are detailed in the above table, are backed with a Company guarantee.
|
(3) |
It is noted that subsequent to the report date, in July 2025, the facility amount increased to approx. NIS 390 million (USD 115 million).
|
A. |
Significant events during and subsequent to the Reporting Period (cont.)
|
2. |
Short-term credit facilities: (cont.)
|
3. |
In May 2025, Midroog has set an initial rating of A1.il with a stable outlook for the Company and its debentures. In addition, in May 2025, Ma’alot S&P upgraded the Company's credit rating to ilA with a stable outlook and the
rating of its debentures to ilA+, following an improvement in business profile and financial ratios.
|
B. |
Changes in the Group’s material guarantees:
|
As of
June 30, 2025
|
As of
December 31, 2024
|
|||||||
NIS million
|
NIS million
|
|||||||
In respect of operating projects in Israel (Rotem, Hadera, Zomet and Gat) (1)
|
163
|
249
|
||||||
For projects under construction and development in Israel (Sorek 2 and consumers’ premises)
|
74
|
74
|
||||||
In respect of the filing of a bid in the Sorek tender (2)
|
50
|
100
|
||||||
In respect of virtual supply activity in Israel (3)
|
87
|
21
|
||||||
In respect of operating projects in the US Renewable Energy Segment*
|
20
|
22
|
||||||
In respect of projects under construction and development in the US (CPV Group)*
|
277
|
339
|
||||||
Total
|
671
|
805
|
(1) |
The decrease arises mainly from the release of a bank guarantee provided by OPC Israel for Zomet in favor of ILA totaling NIS 67 million (for further details, see Note 10B5 to the Annual Financial Statements).
|
(2) |
The decrease arises from a decrease in bank guarantee provided by OPC Israel in connection with the Sorek tender as described in Note 14C3 to the Annual Financial Statements.
|
(3) |
The increase stems from an increase of the bank guarantee provided in favor of the System Operator in respect of the virtual supply activity due to seasonality.
|
C. |
Financial covenants:
|
Ratio
|
Required value – Series B
|
Required value – Series C and D
|
Actual value
|
|||
Net financial debt (1) to adjusted EBITDA (2)
|
Will not exceed 13 (for distribution purposes – 11)
|
Will not exceed 13 (for distribution purposes – 11)
|
4.3
|
|||
The Company shareholders’ equity (“separate”)
|
Will not fall below NIS 250 million (for distribution purposes – NIS 350 million)
|
With respect to Debentures (Series C): will not fall below NIS 1 billion (for distribution purposes – NIS 1.4 billion)
With respect to Debentures (Series D): will not fall below NIS 2 billion (for distribution purposes – NIS 2.4 billion)
|
Approx.
NIS 5,275 million
|
|||
The Company’s equity to asset ratio (“separate”)
|
Will not fall below 17% (for distribution purposes: 27%)
|
Will not fall below 20% (for distribution purposes – 30%)
|
74%
|
|||
The Company’s equity to asset ratio (“consolidated”)
|
--
|
Will not fall below 17%
|
54%
|
C. |
Financial covenants: (cont.)
|
Financial covenants
|
Breach ratio
|
Actual value
|
Covenants applicable to OPC Israel with respect to the corporate financing agreements3
|
||||
OPC Israel’s equity capital
|
Will not fall below NIS 1,100 million
|
Approx. NIS 2,194 million
|
||
OPC Israel’s equity to asset ratio
|
Will not fall below 20%
|
39%
|
||
OPC Israel’s ratio of net debt to EBITDA
|
Will not exceed 8
|
3.8
|
Covenants applicable to Hadera in connection with the Hadera Financing Agreement
|
||||
Minimum expected DSCR
|
1.10
|
1.13
|
||
Average expected DSCR
|
1.10
|
1.66
|
||
LLCR
|
1.10
|
1.57
|
Covenants applicable to the Company in connection with binding credit facilities with Israeli banking corporations4
|
||||
The Company shareholders’ equity (“separate”)
|
Will not fall below NIS 1,200 million
|
Approx. NIS 5,288 million
|
||
The Company’s equity to asset ratio (“separate”)
|
Will not fall below 30%
|
74%
|
||
The Company’s net debt to EBITDA ratio
|
Will not exceed 12
|
4.3
|
3 |
Additionally, OPC Israel has short-term bank credit facilities, which include financial covenants, which are not stricter than the abovementioned financial covenants.
|
4 |
Additionally, the Company has financial covenants applicable by virtue of the Hadera Equity Subscription Agreement, which are not stricter than the abovementioned covenants.
|
D. |
Shares issuance
|
E. |
Shelf prospectus
|
F. |
Equity compensation plans
|
1. |
Allocations of offered securities in the Reporting Period and thereafter:
|
Offerees and allotment date
|
No. of options at the grant date (in thousands)
|
Average fair value of each option at the grant date (in NIS)
|
Exercise price per option (in NIS, unlinked)
|
Standard deviation (1)
|
Risk-free interest rate (2)
|
Cost of benefit (in NIS million) (3)
|
|||||||||||||||
Executives, March 2025
|
441
|
11.80
|
31.98
|
30.4%-34.5%
|
4.09%-4.15%
|
Approx. 5.0
|
|||||||||||||||
CEO, July 2025 (4)
|
646
|
17.74
|
43.39
|
30.82%-32.52%
|
|
3.96%-3.98%
|
Approx. 11.5
|
(1) |
The standard deviation is calculated based on historical volatility of the Company’s share over the expected life of the option until exercise date.
|
(2) |
The rate of the risk-free interest is based on the Fair Spread database and an expected life of 4 to 6 years.
|
(3) |
This amount will be recorded in profit and loss over the vesting period of each tranche.
|
(4) |
The allocation is subject to the approval of the general meeting of shareholders, which was scheduled for August 2025. The fair value data of the options in the above table were calculated immediately prior to the date of the Board of
Directors’ approval – July 21, 2025.
|
2. |
Exercise of options and issuance of shares:
|
3. |
Expiry of options during
the Reporting Period
|
G. |
Profit-sharing plan for CPV Group employees
|
A. |
Commitments (Including with Related and Interested Parties)
|
B. |
Claims and other liabilities
|
A. |
Financial instruments measured at fair value for disclosure purposes only
|
As of June 30, 2025
|
||||||||
Carrying value (*)
|
Fair value
|
|||||||
In NIS million
|
(Unaudited)
|
(Unaudited)
|
||||||
Loans from banking corporations and financial institutions (Level 2)
|
2,496
|
2,513
|
||||||
Loans from non‑controlling interests (Level 2)
|
457
|
458
|
||||||
Debentures (Level 1)
|
1,797
|
1,754
|
||||||
4,750
|
4,725
|
As of June 30, 2024
|
||||||||
Carrying value (*)
|
Fair value
|
|||||||
In NIS million
|
(Unaudited)
|
(Unaudited)
|
||||||
Loans from banking corporations and financial institutions (Level 2)
|
3,028
|
3,065
|
||||||
Loans from non‑controlling interests (Level 2)
|
498
|
501
|
||||||
Debentures (Level 1)
|
1,978
|
1,876
|
||||||
5,504
|
5,442
|
As of December 31, 2024
|
||||||||
Carrying value (*)
|
Fair value
|
|||||||
In NIS million
|
(Audited)
|
(Audited)
|
||||||
Loans from banking corporations and financial institutions (Level 2)
|
2,234
|
2,237
|
||||||
Loans from non‑controlling interests (Level 2)
|
514
|
508
|
||||||
Debentures (Level 1)
|
1,891
|
1,805
|
||||||
4,639
|
4,550
|
B. |
Fair value hierarchy of financial instruments measured at fair value
|
As of June 30
|
As of December 31
|
|||||||||||
2025
|
2024
|
2024
|
||||||||||
In NIS million
|
(Unaudited)
|
(Audited)
|
||||||||||
Financial assets
|
||||||||||||
Derivatives used for hedge accounting
|
||||||||||||
CPI swap contracts (Level 2)
|
40
|
42
|
(*)44
|
|
||||||||
Interest rate swaps (SOFR) (Level 2) (1)
|
-
|
31
|
-
|
|||||||||
Total
|
40
|
73
|
44
|
|||||||||
Financial liabilities
|
||||||||||||
Derivatives used for hedge accounting
|
||||||||||||
CPI swap contracts (Level 2)
|
(1
|
)
|
(2
|
)
|
(*)(1
|
)
|
||||||
Interest rate swaps (SOFR) (Level 2) (1)
|
-
|
(2
|
)
|
-
|
||||||||
Electricity price hedge contracts (the US renewable energy segment) (Level 3) (1)
|
-
|
(48
|
)
|
-
|
||||||||
Total
|
(1
|
)
|
(52
|
)
|
(1
|
)
|
(1) |
The balances as of June 30, 2024 are in respect of CPV Renewable. For details regarding deconsolidation and transition to the equity method in the fourth quarter of 2024 with respect to the investment in CPV Renewable, see Note 23E to
the Annual Financial Statements.
|
A. |
General
|
1. |
Further to Note 1 to the Annual Financial Statements, in June 2025, there was a further escalation of the geopolitical situation, with the outbreak of a large-scale military conflict between Israel and Iran
(hereinafter – “Operation Rising Lion"), which included missile attacks by Iran, the closure of Israeli airspace, a general state of
emergency in the Israeli home front and a substantial escalation in the regional arena. On June 24, 2025, a ceasefire with Iran was declared, which is in place as of the report approval date. Operation Rising Lion did not have a
material effect on the operating results in Israel in the Reporting Period.
|
2. |
In the six‑month periods
ended June 30, 2025 and 2024 the Group purchased property, plant and equipment for a total of approx. NIS 104 million and approx. NIS 512 million, respectively. Furthermore, these amounts include non-cash purchases totaling approx.
NIS 3 million and approx. NIS 32 million during these periods, respectively.
|
3. |
For further details regarding developments in credit from banking corporations and others, debentures, credit ratings of the Company and its debentures, guarantees and equity in the Reporting Period and thereafter, see Note 6.
|
4. |
For further details regarding developments in commitments (including with related parties and interested parties), claims and other commitments during the Reporting Period and thereafter, see Note 7.
|
B. |
OPC Israel
|
C. |
CPV Group
|
1. |
Further to Note 24C to the Annual Financial Statements regarding an agreement to acquire a further 20% stake in the Shore Power Plant, such that subsequent to its completion, the holding stake will be approx. 89% – on April 1, 2025,
the acquisition agreement was completed. At the transaction completion date, the CPV Group paid the Seller a consideration amount that is immaterial to the Company, in addition to injecting the Partner's share on Shore’s refinancing date
during the first quarter of 2025, as detailed in Note 10 below. Most of the excess acquisition cost was allocated to property, plant, and equipment. Given the current interests, as of the report date, of the remaining partner in the Shore
Power Plant, as of that date, the Company continues to account for its investment in Shore in accordance with the equity method.
|
2. |
Further to Note 23E to the Annual Financial Statements regarding the investment agreement in the US Renewable Energy Segment, a further total of approx. USD 50 million was invested in April 2025 by the Investor.
|
3. |
Further to Note 23A3 to the Annual Financial Statements, following is information regarding investment undertakings and provision of loans by OPC Power’s partners (in USD million):
|
Immediately prior to the report approval date
|
As of June 30, 2025
|
As of December 31, 2024
|
||||||||||
Total investment undertakings and loan provision (a)
|
1,535
|
1,535
|
1,535
|
|||||||||
Utilization (b)
|
(1,510
|
)
|
(1,510
|
)
|
(1,455
|
)
|
||||||
Balance of investment undertakings and loan provision
|
25
|
25
|
80
|
A. |
Excluding an additional investment commitment for backing guarantees which were or will be provided for the purpose of
development and expansion of projects – each partner based on its pro rata share in the partnership, for a total of approx. USD 75 million.
|
B. |
In the Reporting Period, the Company
and non-controlling interests (both directly and indirectly) made equity investments in the Partnership and advanced loans totaling approx. USD 42 million (approx. NIS 146 million) and approx. USD 13 million (approx. NIS 48 million),
respectively.
|
4. |
Dividends and capital distributions from associates
|
As of June 30, 2025
|
||||||||||||||||
US GAAP
|
Adjustments
|
IFRS
|
||||||||||||||
In USD thousand
|
In USD thousand
|
In USD thousand
|
||||||||||||||
Cash and cash equivalents
|
D |
76
|
200
|
276
|
||||||||||||
Restricted cash
|
D |
7,511
|
(200
|
)
|
7,311
|
|||||||||||
Property, plant & equipment
|
A,C
|
784,128
|
57,857
|
841,985
|
||||||||||||
Intangible assets
|
C |
25,448
|
(25,448
|
)
|
-
|
|||||||||||
Other assets
|
32,571
|
-
|
32,571
|
|||||||||||||
Total assets
|
849,734
|
32,409
|
882,143
|
|||||||||||||
Accounts payable and deferred expenses
|
A |
12,525
|
(6,580
|
)
|
5,945
|
|||||||||||
Other liabilities
|
505,684
|
(8,078
|
)
|
497,606
|
||||||||||||
Total liabilities
|
518,209
|
(14,658
|
)
|
503,551
|
||||||||||||
Partners’ equity
|
A |
331,525
|
47,067
|
378,592
|
||||||||||||
Total liabilities and equity
|
849,734
|
32,409
|
882,143
|
As of June 30, 2024
|
||||||||||||||||
US GAAP
|
Adjustments
|
IFRS
|
||||||||||||||
In USD thousand
|
In USD thousand
|
In USD thousand
|
||||||||||||||
Cash and cash equivalents
|
D |
73
|
2,569
|
2,642
|
||||||||||||
Restricted cash
|
D |
2,674
|
(2,569
|
)
|
105
|
|||||||||||
Property, plant & equipment
|
A,C
|
806,261
|
54,706
|
860,967
|
||||||||||||
Intangible assets
|
C |
26,318
|
(26,318
|
)
|
-
|
|||||||||||
Other assets
|
68,235
|
-
|
68,235
|
|||||||||||||
Total assets
|
903,561
|
28,388
|
931,949
|
|||||||||||||
Accounts payable and deferred expenses
|
A |
18,733
|
(8,743
|
)
|
9,990
|
|||||||||||
Other liabilities
|
345,495
|
280
|
345,775
|
|||||||||||||
Total liabilities
|
364,228
|
(8,463
|
)
|
355,765
|
||||||||||||
Partners’ equity
|
A |
|
539,333
|
36,851
|
576,184
|
|||||||||||
Total liabilities and equity
|
903,561
|
28,388
|
931,949
|
As of December 31, 2024
|
||||||||||||||||
US GAAP
|
Adjustments
|
IFRS
|
||||||||||||||
In USD thousand
|
In USD thousand
|
In USD thousand
|
||||||||||||||
Cash and cash equivalents
|
D |
43
|
444
|
487
|
||||||||||||
Restricted cash
|
D |
4,793
|
(444
|
)
|
4,349
|
|||||||||||
Property, plant & equipment
|
A,C
|
|
797,304
|
57,331
|
854,635
|
|||||||||||
Intangible assets
|
C |
|
25,883
|
(25,883
|
)
|
-
|
||||||||||
Other assets
|
36,526
|
-
|
36,526
|
|||||||||||||
Total assets
|
864,549
|
31,448
|
895,997
|
|||||||||||||
Accounts payable and deferred expenses
|
A |
|
13,820
|
(6,360
|
)
|
7,460
|
||||||||||
Other liabilities
|
530,317
|
-
|
530,317
|
|||||||||||||
Total liabilities
|
544,137
|
(6,360
|
)
|
537,777
|
||||||||||||
Partners’ equity
|
A |
|
320,412
|
37,808
|
358,220
|
|||||||||||
Total liabilities and equity
|
864,549
|
31,448
|
895,997
|
For the six-month period ended June 30, 2025
|
||||||||||||||||||||
US GAAP
|
IFRS adjustments
|
Adjustments to the Group’s accounting policies*
|
IFRS – according to the Group’s accounting policies
|
|||||||||||||||||
In USD thousand
|
In USD thousand
|
In USD thousand
|
In USD thousand
|
|||||||||||||||||
Revenues
|
B |
199,815
|
(1,145
|
)
|
(4,051
|
)
|
194,619
|
|||||||||||||
Operating expenses
|
A |
103,580
|
(4,712
|
)
|
(4,051
|
)
|
94,817
|
|||||||||||||
Depreciation and amortization
|
A |
13,894
|
3,531
|
-
|
17,425
|
|||||||||||||||
Operating profit
|
82,341
|
36
|
-
|
82,377
|
||||||||||||||||
Finance expenses
|
B,F
|
19,086
|
(9,565
|
)
|
-
|
9,521
|
||||||||||||||
Profit for the period
|
63,255
|
9,601
|
-
|
72,856
|
||||||||||||||||
Other comprehensive loss
|
B |
|
(19,642
|
)
|
(342
|
)
|
-
|
(19,984
|
)
|
|||||||||||
Comprehensive income for the period
|
43,613
|
9,259
|
-
|
52,872
|
For the six-month period ended June 30, 2024
|
||||||||||||||||||||
US GAAP
|
IFRS adjustments
|
Adjustments to the Group’s accounting policies*
|
IFRS – according to the Group’s accounting policies
|
|||||||||||||||||
In USD thousand
|
In USD thousand
|
In USD thousand
|
In USD thousand
|
|||||||||||||||||
Revenues
|
B |
|
143,616
|
(1,381
|
)
|
9,841
|
152,076
|
|||||||||||||
Operating expenses
|
A |
65,084
|
(4,440
|
)
|
9,841
|
70,485
|
||||||||||||||
Depreciation and amortization
|
A |
13,724
|
3,531
|
-
|
17,255
|
|||||||||||||||
Operating profit
|
64,808
|
(472
|
)
|
-
|
64,336
|
|||||||||||||||
Finance expenses
|
B |
7,714
|
(3,197
|
)
|
-
|
4,517
|
||||||||||||||
Profit for the period
|
57,094
|
2,725
|
-
|
59,819
|
||||||||||||||||
Other comprehensive loss
|
B |
(2,038
|
)
|
(1,676
|
)
|
-
|
(3,714
|
)
|
||||||||||||
Comprehensive income for the period
|
55,056
|
1,049
|
-
|
56,105
|
For the three-month period ended June 30, 2025
|
||||||||||||||||||||
US GAAP
|
IFRS adjustments
|
Adjustments to the Group’s accounting policies*
|
IFRS – according to the Group’s accounting policies
|
|||||||||||||||||
In USD thousand
|
In USD thousand
|
In USD thousand
|
In USD thousand
|
|||||||||||||||||
Revenues
|
B |
|
87,440
|
831
|
2,370
|
90,641
|
||||||||||||||
Operating expenses
|
A |
38,941
|
(2,266
|
)
|
2,370
|
39,045
|
||||||||||||||
Depreciation and amortization
|
A |
6,951
|
1,766
|
-
|
8,717
|
|||||||||||||||
Operating profit
|
41,548
|
1,331
|
-
|
42,879
|
||||||||||||||||
Finance expenses
|
B,F |
9,253
|
(239
|
)
|
-
|
9,014
|
||||||||||||||
Profit for the period
|
32,295
|
1,570
|
-
|
33,865
|
||||||||||||||||
Other comprehensive loss
|
B |
(6,446
|
)
|
(1,547
|
)
|
-
|
(7,993
|
)
|
||||||||||||
Comprehensive income for the period
|
25,849
|
23
|
-
|
25,872
|
For the three-month period ended June 30, 2024
|
||||||||||||||||||||
US GAAP
|
IFRS adjustments
|
Adjustments to the Group’s accounting policies*
|
IFRS – according to the Group’s accounting policies
|
|||||||||||||||||
In USD thousand
|
In USD thousand
|
In USD thousand
|
In USD thousand
|
|||||||||||||||||
Revenues
|
B |
60,690
|
92
|
6,520
|
67,302
|
|||||||||||||||
Operating expenses
|
A |
25,792
|
(2,021
|
)
|
6,520
|
30,291
|
||||||||||||||
Depreciation and amortization
|
A |
6,864
|
1,765
|
-
|
8,629
|
|||||||||||||||
Operating profit
|
28,034
|
348
|
-
|
28,382
|
||||||||||||||||
Finance expenses
|
B |
4,816
|
(1,030
|
)
|
-
|
3,786
|
||||||||||||||
Profit for the period
|
23,218
|
1,378
|
-
|
24,596
|
||||||||||||||||
Other comprehensive income
|
B |
3,549
|
(1,052
|
)
|
-
|
2,497
|
||||||||||||||
Comprehensive income for the period
|
26,767
|
326
|
-
|
27,093
|
For the year ended December 31, 2024
|
||||||||||||||||||||
US GAAP
|
IFRS adjustments
|
Adjustments to the Group’s accounting policies*
|
IFRS – according to the Group’s accounting policies
|
|||||||||||||||||
In USD thousand
|
In USD thousand
|
In USD thousand
|
In USD thousand
|
|||||||||||||||||
Revenues
|
B |
275,102
|
(2,854
|
)
|
27,083
|
299,331
|
||||||||||||||
Operating expenses
|
A |
121,590
|
(8,648
|
)
|
27,083
|
140,025
|
||||||||||||||
Depreciation and amortization
|
A |
27,485
|
7,062
|
-
|
34,547
|
|||||||||||||||
Operating profit
|
126,027
|
(1,268
|
)
|
-
|
124,759
|
|||||||||||||||
Finance expenses
|
B |
27,325
|
(5,185
|
)
|
-
|
22,140
|
||||||||||||||
Profit for the year
|
98,702
|
3,917
|
-
|
102,619
|
||||||||||||||||
Other comprehensive income
|
9,533
|
(1,911
|
)
|
-
|
7,622
|
|||||||||||||||
Comprehensive income for the year
|
108,235
|
2,006
|
-
|
110,241
|
For the six-month period ended June 30, 2025
|
||||||||||||||||
US GAAP
|
Adjustments
|
IFRS
|
||||||||||||||
In USD thousand
|
In USD thousand
|
In USD thousand
|
||||||||||||||
Profit for the period
|
A, B
|
|
63,255
|
9,601
|
72,856
|
|||||||||||
Net cash provided by operating activities
|
68,819
|
-
|
68,819
|
|||||||||||||
Net cash used for investing activities
|
|
(282
|
)
|
(2,962
|
)
|
(3,244
|
)
|
|||||||||
Net cash used for financing activities
|
(65,786
|
)
|
-
|
(65,786
|
)
|
|||||||||||
Net increase (decrease) in cash and cash equivalents
|
2,751
|
(2,962
|
)
|
(211
|
)
|
|||||||||||
Balance of cash and cash equivalents as of the beginning of the period
|
D |
43
|
444
|
487
|
||||||||||||
Restricted cash balance as of the beginning of the period
|
D |
4,793
|
(4,793
|
)
|
-
|
|||||||||||
Balance of cash and cash equivalents as of the end of the period
|
D |
76
|
200
|
276
|
||||||||||||
Restricted cash balance as of the end of the period
|
D |
7,511
|
(7,511
|
)
|
-
|
For the six-month period ended June 30, 2024
|
||||||||||||||||
US GAAP
|
Adjustments
|
IFRS
|
||||||||||||||
In USD thousand
|
In USD thousand
|
In USD thousand
|
||||||||||||||
Profit for the period
|
|
|
57,094
|
2,725
|
59,819
|
|||||||||||
Net cash provided by operating activities
|
70,472
|
-
|
70,472
|
|||||||||||||
Net cash used for investing activities
|
D |
|
(2,234
|
)
|
1,219
|
(1,015
|
)
|
|||||||||
Net cash used for financing activities
|
(67,132
|
)
|
-
|
(67,132
|
)
|
|||||||||||
Net increase in cash and cash equivalents
|
1,106
|
1,219
|
2,325
|
|||||||||||||
Balance of cash and cash equivalents as of the beginning of the period
|
D |
52
|
265
|
317
|
||||||||||||
Restricted cash balance as of the beginning of the period
|
D |
28,328
|
(28,328
|
)
|
-
|
|||||||||||
Balance of cash and cash equivalents as of the end of the period
|
D |
73
|
2,569
|
2,642
|
||||||||||||
Restricted cash balance as of the end of the period
|
D |
29,413
|
(29,413
|
)
|
-
|
For the three-month period ended June 30, 2025
|
||||||||||||||||
US GAAP
|
Adjustments
|
IFRS
|
||||||||||||||
In USD thousand
|
In USD thousand
|
In USD thousand
|
||||||||||||||
Profit for the period
|
A,B |
32,295
|
1,570
|
33,865
|
||||||||||||
Net cash provided by operating activities
|
31,155
|
-
|
31,155
|
|||||||||||||
Net cash used for investing activities
|
(282
|
)
|
(841
|
)
|
(1,123
|
)
|
||||||||||
Net cash used for financing activities
|
(30,000
|
)
|
-
|
(30,000
|
)
|
|||||||||||
Net increase in cash and cash equivalents
|
D |
873
|
(841
|
)
|
32
|
|||||||||||
Balance of cash and cash equivalents as of the beginning of the period
|
D |
76
|
168
|
244
|
||||||||||||
Restricted cash balance as of the beginning of the period
|
D |
6,638
|
(6,638
|
)
|
-
|
|||||||||||
Balance of cash and cash equivalents as of the end of the period
|
D |
76
|
200
|
276
|
||||||||||||
Restricted cash balance as of the end of the period
|
D |
7,511
|
(7,511
|
)
|
-
|
For the three-month period ended June 30, 2024
|
||||||||||||||||
US GAAP
|
Adjustments
|
IFRS
|
||||||||||||||
In USD thousand
|
In USD thousand
|
In USD thousand
|
||||||||||||||
Profit for the period
|
23,218
|
1,378
|
24,596
|
|||||||||||||
Net cash provided by operating activities
|
29,305
|
-
|
29,305
|
|||||||||||||
Net cash used for investing activities
|
D |
(1,327
|
)
|
(1,607
|
)
|
(2,934
|
)
|
|||||||||
Net cash used for financing activities
|
(26,462
|
)
|
-
|
(26,462
|
)
|
|||||||||||
Net increase (decrease) in cash and cash equivalents
|
1,516
|
(1,607
|
)
|
(91
|
)
|
|||||||||||
Balance of cash and cash equivalents as of the beginning of the period
|
D |
82
|
2,651
|
2,733
|
||||||||||||
Restricted cash balance as of the beginning of the period
|
D |
27,888
|
(27,888
|
)
|
-
|
|||||||||||
Balance of cash and cash equivalents as of the end of the period
|
D |
73
|
2,569
|
2,642
|
||||||||||||
Restricted cash balance as of the end of the period
|
D |
29,413
|
(29,413
|
)
|
-
|
For the year ended December 31, 2024
|
||||||||||||||||
US GAAP
|
Adjustments
|
IFRS
|
||||||||||||||
In USD thousand
|
In USD thousand
|
In USD thousand
|
||||||||||||||
Profit for the year
|
A,B
|
|
98,702
|
3,917
|
102,619
|
|||||||||||
Net cash provided by operating activities
|
125,851
|
-
|
125,851
|
|||||||||||||
Net cash provided by (used for) investing activities
|
D |
|
(11,286
|
)
|
23,714
|
12,428
|
||||||||||
Net cash used for financing activities
|
(138,109
|
)
|
-
|
(138,109
|
)
|
|||||||||||
Net increase (decrease) in cash and cash equivalents
|
(23,544
|
)
|
23,714
|
170
|
||||||||||||
Balance of cash and cash equivalents as of the beginning of the year
|
D |
52
|
265
|
317
|
||||||||||||
Restricted cash balance as of the beginning of the year
|
D |
28,328
|
(28,328
|
)
|
-
|
|||||||||||
Balance of cash and cash equivalents as of the end of the year
|
D |
43
|
444
|
487
|
||||||||||||
Restricted cash balance as of the end of the year
|
D |
4,793
|
(4,793
|
)
|
-
|
As of June 30, 2025
|
||||||||||||||||
US GAAP
|
Adjustments
|
IFRS
|
||||||||||||||
In USD thousand
|
In USD thousand
|
In USD thousand
|
||||||||||||||
Cash and cash equivalents
|
D |
99
|
18,713
|
18,812
|
||||||||||||
Restricted cash
|
D |
35,819
|
(18,713
|
)
|
17,106
|
|||||||||||
Property, plant & equipment
|
A,C
|
742,060
|
87,931
|
829,991
|
||||||||||||
Intangible assets
|
C |
46,069
|
(46,069
|
)
|
-
|
|||||||||||
Other assets
|
E |
54,212
|
(5
|
)
|
54,207
|
|||||||||||
Total assets
|
878,259
|
41,857
|
920,116
|
|||||||||||||
Accounts payable and deferred expenses
|
A |
57,218
|
(1,139
|
)
|
56,079
|
|||||||||||
Other liabilities
|
260,341
|
(395
|
)
|
259,946
|
||||||||||||
Total liabilities
|
317,559
|
(1,534
|
)
|
316,025
|
||||||||||||
Partners’ equity
|
A |
560,700
|
43,391
|
604,091
|
||||||||||||
Total liabilities and equity
|
878,259
|
41,857
|
920,116
|
As of June 30, 2024
|
||||||||||||||||
US GAAP
|
Adjustments
|
IFRS
|
||||||||||||||
In USD thousand
|
In USD thousand
|
In USD thousand
|
||||||||||||||
Cash and cash equivalents
|
D |
99
|
12,160
|
12,259
|
||||||||||||
Restricted cash
|
D |
12,660
|
(12,160
|
)
|
500
|
|||||||||||
Property, plant & equipment
|
A,C
|
728,721
|
80,725
|
809,446
|
||||||||||||
Intangible assets
|
C |
49,578
|
(49,578
|
)
|
-
|
|||||||||||
Other assets
|
74,561
|
-
|
74,561
|
|||||||||||||
Total assets
|
865,619
|
31,147
|
896,766
|
|||||||||||||
Accounts payable and deferred expenses
|
A |
|
12,084
|
(1,910
|
)
|
10,174
|
||||||||||
Other liabilities
|
H |
|
325,753
|
(510
|
)
|
325,243
|
||||||||||
Total liabilities
|
337,837
|
(2,420
|
)
|
335,417
|
||||||||||||
Partners’ equity
|
A |
|
527,782
|
33,567
|
561,349
|
|||||||||||
Total liabilities and equity
|
865,619
|
31,147
|
896,766
|
As of December 31, 2024
|
||||||||||||||||
US GAAP
|
Adjustments
|
IFRS
|
||||||||||||||
In USD thousand
|
In USD thousand
|
In USD thousand
|
||||||||||||||
Cash and cash equivalents
|
D |
99
|
8,969
|
9,068
|
||||||||||||
Restricted cash
|
D |
29,631
|
(8,969
|
)
|
20,662
|
|||||||||||
Property, plant & equipment
|
A,
|
717,309
|
79,455
|
796,764
|
||||||||||||
Intangible assets
|
C |
47,824
|
(47,824
|
)
|
-
|
|||||||||||
Other assets
|
70,362
|
-
|
70,362
|
|||||||||||||
Total assets
|
865,225
|
31,631
|
896,856
|
|||||||||||||
Accounts payable and deferred expenses
|
A |
39,630
|
(2,207
|
)
|
37,423
|
|||||||||||
Other liabilities
|
H |
266,468
|
(450
|
)
|
266,018
|
|||||||||||
Total liabilities
|
306,098
|
(2,657
|
)
|
303,441
|
||||||||||||
Partners’ equity
|
A |
559,127
|
34,288
|
593,415
|
||||||||||||
Total liabilities and equity
|
865,225
|
31,631
|
896,856
|
For the six-month period ended June 30, 2025
|
||||||||||||||||
US GAAP
|
IFRS adjustments
|
IFRS – according to the Group’s accounting policies
|
||||||||||||||
In USD thousand
|
In USD thousand
|
In USD thousand
|
||||||||||||||
Revenues
|
B |
221,159
|
(349
|
)
|
220,810
|
|||||||||||
Operating expenses
|
A,E
|
153,565
|
(14,120
|
)
|
139,445
|
|||||||||||
Depreciation and amortization
|
A,E
|
14,605
|
4,952
|
19,557
|
||||||||||||
Operating profit
|
52,989
|
8,819
|
61,808
|
|||||||||||||
Finance expenses
|
B, E,F
|
8,673
|
(1,048
|
)
|
7,625
|
|||||||||||
Profit for the period
|
44,316
|
9,867
|
54,183
|
|||||||||||||
Other comprehensive loss
|
B |
(7,743
|
)
|
(764
|
)
|
(8,507
|
)
|
|||||||||
Comprehensive income for the period
|
36,573
|
9,103
|
45,676
|
For the six-month period ended June 30, 2024
|
||||||||||||||||
US GAAP
|
IFRS adjustments
|
IFRS – according to the Group’s accounting policies
|
||||||||||||||
In USD thousand
|
In USD thousand
|
In USD thousand
|
||||||||||||||
Revenues
|
B |
218,992
|
(17,292
|
)
|
201,700
|
|||||||||||
Operating expenses
|
A |
130,903
|
(4,277
|
)
|
126,626
|
|||||||||||
Depreciation and amortization
|
A |
14,454
|
2,804
|
17,258
|
||||||||||||
Operating profit
|
73,635
|
(15,819
|
)
|
57,816
|
||||||||||||
Finance expenses
|
B |
10,149
|
(2,611
|
)
|
7,538
|
|||||||||||
Profit for the period
|
63,486
|
(13,208
|
)
|
50,278
|
||||||||||||
Other comprehensive loss
|
B |
(35,006
|
)
|
15,085
|
(19,921
|
)
|
||||||||||
Comprehensive income for the period
|
28,480
|
1,877
|
30,357
|
For the three-month period ended June 30, 2025
|
||||||||||||||||
US GAAP
|
IFRS adjustments
|
IFRS – according to the Group’s accounting policies
|
||||||||||||||
In USD thousand
|
In USD thousand
|
In USD thousand
|
||||||||||||||
Revenues
|
70,087
|
(570
|
)
|
69,517
|
||||||||||||
Operating expenses
|
A,E |
53,854
|
(11,737
|
)
|
42,117
|
|||||||||||
Depreciation and amortization
|
A,E |
7,356
|
2,861
|
10,217
|
||||||||||||
Operating profit
|
8,877
|
8,306
|
17,183
|
|||||||||||||
Finance expenses
|
B,F |
4,488
|
(453
|
)
|
4,035
|
|||||||||||
Profit for the period
|
4,389
|
8,759
|
13,148
|
|||||||||||||
Other comprehensive loss
|
B |
(2,886
|
)
|
96
|
(2,790
|
)
|
||||||||||
Comprehensive income for the period
|
1,503
|
8,855
|
10,358
|
For the three-month period ended June 30, 2024
|
||||||||||||||||
US GAAP
|
IFRS adjustments
|
IFRS – according to the Group’s accounting policies
|
||||||||||||||
In USD thousand
|
In USD thousand
|
In USD thousand
|
||||||||||||||
Revenues
|
84,648
|
(2,085
|
)
|
82,563
|
||||||||||||
Operating expenses
|
A |
47,511
|
(1,910
|
)
|
45,601
|
|||||||||||
Depreciation and amortization
|
A |
7,227
|
1,402
|
8,629
|
||||||||||||
Operating profit
|
29,910
|
(1,577
|
)
|
28,333
|
||||||||||||
Finance expenses
|
B |
5,710
|
(1,529
|
)
|
4,181
|
|||||||||||
Profit for the period
|
24,200
|
(48
|
)
|
24,152
|
||||||||||||
Other comprehensive loss
|
B |
(15,862
|
)
|
978
|
(14,884
|
)
|
||||||||||
Comprehensive income for the period
|
8,338
|
930
|
9,268
|
For the year ended December 31, 2024
|
||||||||||||||||
US GAAP
|
IFRS adjustments
|
IFRS – according to the Group’s accounting policies
|
||||||||||||||
In USD thousand
|
In USD thousand
|
In USD thousand
|
||||||||||||||
Revenues
|
B |
437,675
|
(18,991
|
)
|
418,684
|
|||||||||||
Operating expenses
|
A,E |
257,262
|
(8,779
|
)
|
248,483
|
|||||||||||
Depreciation and amortization
|
A,E |
28,927
|
6,515
|
35,442
|
||||||||||||
Operating profit
|
151,486
|
(16,727
|
)
|
134,759
|
||||||||||||
Finance expenses
|
B |
19,316
|
(4,222
|
)
|
15,094
|
|||||||||||
Profit for the year
|
132,170
|
(12,505
|
)
|
119,665
|
||||||||||||
Other comprehensive loss
|
B,E |
(24,345
|
)
|
15,102
|
(9,243
|
)
|
||||||||||
Comprehensive income for the year
|
107,825
|
2,597
|
110,422
|
For the six-month period ended June 30, 2025
|
||||||||||||||||
US GAAP
|
Adjustments
|
IFRS
|
||||||||||||||
In USD thousand
|
In USD thousand
|
In USD thousand
|
||||||||||||||
Profit for the period
|
A,B
|
|
44,316
|
9,867
|
54,183
|
|||||||||||
Net cash provided by operating activities
|
50,564
|
-
|
50,564
|
|||||||||||||
Net cash provided by (used for) investing activities
|
D |
|
(1,222
|
)
|
3,556
|
2,334
|
||||||||||
Net cash used for financing activities
|
(43,154
|
)
|
-
|
(43,154
|
)
|
|||||||||||
Net increase in cash and cash equivalents
|
6,188
|
3,556
|
9,744
|
|||||||||||||
Balance of cash and cash equivalents as of the beginning of the period
|
D |
99
|
8,969
|
9,068
|
||||||||||||
Restricted cash balance as of the beginning of the period
|
D |
29,631
|
(29,631
|
)
|
-
|
|||||||||||
Balance of cash and cash equivalents as of the end of the period
|
D |
99
|
18,713
|
18,812
|
||||||||||||
Restricted cash balance as of the end of the period
|
D |
35,819
|
(35,819
|
)
|
-
|
For the six-month period ended June 30, 2024
|
||||||||||||||||
US GAAP
|
Adjustments
|
IFRS
|
||||||||||||||
In USD thousand
|
In USD thousand
|
In USD thousand
|
||||||||||||||
Profit for the period
|
|
|
63,486
|
(13,208
|
)
|
50,278
|
||||||||||
Net cash provided by operating activities
|
69,401
|
-
|
69,401
|
|||||||||||||
Net cash provided by (used for) investing activities
|
D |
(575
|
)
|
44,087
|
43,512
|
|||||||||||
Net cash used for financing activities
|
(102,700
|
)
|
-
|
(102,700
|
)
|
|||||||||||
Net increase (decrease) in cash and cash equivalents
|
(33,874
|
)
|
44,087
|
10,213
|
||||||||||||
Balance of cash and cash equivalents as of the beginning of the period
|
D |
100
|
1,946
|
2,046
|
||||||||||||
Restricted cash balance as of the beginning of the period
|
D |
46,767
|
(46,767
|
)
|
-
|
|||||||||||
Balance of cash and cash equivalents as of the end of the period
|
D |
99
|
12,160
|
12,259
|
||||||||||||
Restricted cash balance as of the end of the period
|
D |
12,894
|
(12,894
|
)
|
-
|
For the three-month period ended June 30, 2025
|
||||||||||||||||
US GAAP
|
Adjustments
|
IFRS
|
||||||||||||||
In USD thousand
|
In USD thousand
|
In USD thousand
|
||||||||||||||
Profit for the period
|
4,389
|
8,759
|
13,148
|
|||||||||||||
Net cash provided by operating activities
|
9,182
|
-
|
9,182
|
|||||||||||||
Net cash provided by (used for) investing activities
|
D |
(592
|
)
|
8,975
|
8,383
|
|||||||||||
Net cash used for financing activities
|
(2,733
|
)
|
-
|
(2,733
|
)
|
|||||||||||
Net increase in cash and cash equivalents
|
5,857
|
8,975
|
14,832
|
|||||||||||||
Balance of cash and cash equivalents as of the beginning of the period
|
D |
99
|
3,881
|
3,980
|
||||||||||||
Restricted cash balance as of the beginning of the period
|
D |
29,962
|
(29,962
|
)
|
-
|
|||||||||||
Balance of cash and cash equivalents as of the end of the period
|
D |
99
|
18,713
|
18,812
|
||||||||||||
Restricted cash balance as of the end of the period
|
D |
|
35,819
|
(35,819
|
)
|
-
|
For the three-month period ended June 30, 2024
|
||||||||||||||||
US GAAP
|
Adjustments
|
IFRS
|
||||||||||||||
In USD thousand
|
In USD thousand
|
In USD thousand
|
||||||||||||||
Profit for the period
|
24,200
|
(48
|
)
|
24,152
|
||||||||||||
Net cash provided by operating activities
|
27,618
|
-
|
27,618
|
|||||||||||||
Net cash provided by (used for) investing activities
|
D |
(457
|
)
|
45,397
|
44,940
|
|||||||||||
Net cash used for financing activities
|
(61,263
|
)
|
-
|
(61,263
|
)
|
|||||||||||
Net increase (decrease) in cash and cash equivalents
|
(34,102
|
)
|
45,397
|
11,295
|
||||||||||||
Balance of cash and cash equivalents as of the beginning of the period
|
D |
98
|
866
|
964
|
||||||||||||
Restricted cash balance as of the beginning of the period
|
D |
46,997
|
(46,997
|
)
|
-
|
|||||||||||
Balance of cash and cash equivalents as of the end of the period
|
D |
99
|
12,160
|
12,259
|
||||||||||||
Restricted cash balance as of the end of the period
|
D |
12,894
|
(12,894
|
)
|
-
|
For the year ended December 31, 2024
|
||||||||||||||||
US GAAP
|
Adjustments
|
IFRS
|
||||||||||||||
In USD thousand
|
In USD thousand
|
In USD thousand
|
||||||||||||||
Profit for the year
|
A,B
|
|
132,170
|
(12,505
|
)
|
119,665
|
||||||||||
Net cash provided by operating activities
|
164,646
|
-
|
164,646
|
|||||||||||||
Net cash provided by (used for) investing activities
|
D |
(1,882
|
)
|
24,159
|
22,277
|
|||||||||||
Net cash used for financing activities
|
(179,901
|
)
|
-
|
(179,901
|
)
|
|||||||||||
Net increase (decrease) in cash and cash equivalents
|
(17,137
|
)
|
24,159
|
7,022
|
||||||||||||
Balance of cash and cash equivalents as of the beginning of the year
|
D |
100
|
1,946
|
2,046
|
||||||||||||
Restricted cash balance as of the beginning of the year
|
D |
46,767
|
(46,767
|
)
|
-
|
|||||||||||
Balance of cash and cash equivalents as of the end of the year
|
D |
99
|
8,969
|
9,068
|
||||||||||||
Restricted cash balance as of the end of the year
|
D |
29,631
|
(29,631
|
)
|
-
|
As of June 30, 2025
|
||||||||||||||||
US GAAP
|
Adjustments
|
IFRS
|
||||||||||||||
In USD thousand
|
In USD thousand
|
In USD thousand
|
||||||||||||||
Cash and cash equivalents
|
D |
|
44
|
4,446
|
4,490
|
|||||||||||
Restricted cash
|
D |
4,447
|
(4,446
|
)
|
1
|
|||||||||||
Property, plant & equipment
|
A,C
|
559,504
|
42,962
|
602,466
|
||||||||||||
Intangible assets
|
C |
12,442
|
(12,442
|
)
|
-
|
|||||||||||
Other assets
|
74,255
|
-
|
74,255
|
|||||||||||||
Total assets
|
650,692
|
30,520
|
681,212
|
|||||||||||||
Accounts payable and deferred expenses
|
A |
13,822
|
(1,769
|
)
|
12,053
|
|||||||||||
Other liabilities
|
F |
325,464
|
(4,980
|
)
|
320,484
|
|||||||||||
Total liabilities
|
339,286
|
(6,749
|
)
|
332,537
|
||||||||||||
Partners’ equity
|
A
|
311,406
|
37,269
|
348,675
|
||||||||||||
Total liabilities and equity
|
650,692
|
30,520
|
681,212
|
As of June 30, 2024
|
||||||||||||||||
US GAAP
|
Adjustments
|
IFRS
|
||||||||||||||
In USD thousand
|
In USD thousand
|
In USD thousand
|
||||||||||||||
Cash and cash equivalents
|
D |
44
|
895
|
939
|
||||||||||||
Restricted cash
|
D |
896
|
(895
|
)
|
1
|
|||||||||||
Property, plant & equipment
|
A,C
|
575,883
|
41,369
|
617,252
|
||||||||||||
Intangible assets
|
C |
12,841
|
(14,562
|
)
|
(1,721
|
)
|
||||||||||
Other assets
|
79,265
|
-
|
79,265
|
|||||||||||||
Total assets
|
668,929
|
26,807
|
695,736
|
|||||||||||||
Accounts payable and deferred expenses
|
A |
9,154
|
(1,512
|
)
|
7,642
|
|||||||||||
Other liabilities
|
F |
374,057
|
(489
|
)
|
373,568
|
|||||||||||
Total liabilities
|
383,211
|
(2,001
|
)
|
381,210
|
||||||||||||
Partners’ equity
|
A
|
285,718
|
28,808
|
314,526
|
||||||||||||
Total liabilities and equity
|
668,929
|
26,807
|
695,736
|
As of December 31, 2024
|
||||||||||||||||
US GAAP
|
Adjustments
|
IFRS
|
||||||||||||||
In USD thousand
|
In USD thousand
|
In USD thousand
|
||||||||||||||
Cash and cash equivalents
|
D |
34
|
4,800
|
4,834
|
||||||||||||
Restricted cash
|
D |
4,800
|
(4,800
|
)
|
-
|
|||||||||||
Property, plant & equipment
|
A,C
|
567,685
|
41,156
|
608,841
|
||||||||||||
Intangible assets
|
C |
12,641
|
(12,641
|
)
|
-
|
|||||||||||
Other assets
|
76,181
|
(1
|
)
|
76,180
|
||||||||||||
Total assets
|
661,341
|
28,514
|
689,855
|
|||||||||||||
Accounts payable and deferred expenses
|
A |
11,770
|
(1,375
|
)
|
10,395
|
|||||||||||
Other liabilities
|
F |
336,376
|
(2,784
|
)
|
333,592
|
|||||||||||
Total liabilities
|
348,146
|
(4,159
|
)
|
343,987
|
||||||||||||
Partners’ equity
|
A
|
313,195
|
32,673
|
345,868
|
||||||||||||
Total liabilities and equity
|
661,341
|
28,514
|
689,855
|
For the six-month period ended June 30, 2025
|
||||||||||||||||
US GAAP
|
Adjustments
|
IFRS
|
||||||||||||||
In USD thousand
|
In USD thousand
|
In USD thousand
|
||||||||||||||
Revenues
|
146,023
|
21
|
146,044
|
|||||||||||||
Operating expenses
|
A |
101,407
|
(3,669
|
)
|
97,738
|
|||||||||||
Depreciation and amortization
|
G |
9,680
|
(926
|
)
|
8,754
|
|||||||||||
Operating profit
|
34,936
|
4,616
|
39,552
|
|||||||||||||
Finance expenses
|
B |
10,416
|
(3
|
)
|
10,413
|
|||||||||||
Profit for the period
|
24,520
|
4,619
|
29,139
|
|||||||||||||
Other comprehensive loss
|
B |
(13,859
|
)
|
(24
|
)
|
(13,883
|
)
|
|||||||||
Comprehensive income for the period
|
10,661
|
4,595
|
15,256
|
For the six-month period ended June 30, 2024
|
||||||||||||||||
US GAAP
|
Adjustments
|
IFRS
|
||||||||||||||
In USD thousand
|
In USD thousand
|
In USD thousand
|
||||||||||||||
Revenues
|
116,554
|
(383
|
)
|
116,171
|
||||||||||||
Operating expenses
|
A |
|
94,319
|
(2,982
|
)
|
91,337
|
||||||||||
Depreciation and amortization
|
G |
|
9,101
|
2,179
|
11,280
|
|||||||||||
Operating profit
|
13,134
|
420
|
13,554
|
|||||||||||||
Finance expenses
|
B |
11,714
|
(43
|
)
|
11,671
|
|||||||||||
Profit for the period
|
1,420
|
463
|
1,883
|
|||||||||||||
Other comprehensive loss
|
B |
(5,458
|
)
|
340
|
(5,118
|
)
|
||||||||||
Comprehensive loss for the period
|
(4,038
|
)
|
803
|
(3,235
|
)
|
For the three-month period ended June 30, 2025
|
||||||||||||||||
US GAAP
|
Adjustments
|
IFRS
|
||||||||||||||
In USD thousand
|
In USD thousand
|
In USD thousand
|
||||||||||||||
Revenues
|
73,950
|
58
|
74,008
|
|||||||||||||
Operating expenses
|
A |
48,940
|
(1,763
|
)
|
47,177
|
|||||||||||
Depreciation and amortization
|
A |
4,841
|
1,139
|
5,980
|
||||||||||||
Operating profit
|
20,169
|
682
|
20,851
|
|||||||||||||
Finance expenses
|
B,F |
5,007
|
(4
|
)
|
5,003
|
|||||||||||
Profit for the period
|
15,162
|
686
|
15,848
|
|||||||||||||
Other comprehensive income
|
B |
1,115
|
(63
|
)
|
1,052
|
|||||||||||
Comprehensive income
for the period
|
16,277
|
623
|
16,900
|
For the three-month period ended June 30, 2024
|
||||||||||||||||
US GAAP
|
Adjustments
|
IFRS
|
||||||||||||||
In USD thousand
|
In USD thousand
|
In USD thousand
|
||||||||||||||
Revenues
|
58,420
|
(178
|
)
|
58,242
|
||||||||||||
Operating expenses
|
A |
44,180
|
(1,510
|
)
|
42,670
|
|||||||||||
Depreciation and amortization
|
A |
4,804
|
1,089
|
5,893
|
||||||||||||
Operating profit
|
9,436
|
243
|
9,679
|
|||||||||||||
Finance expenses
|
B,F |
6,152
|
(17
|
)
|
6,135
|
|||||||||||
Profit for the
period
|
3,284
|
260
|
3,544
|
|||||||||||||
Other comprehensive income
|
B |
13,698
|
160
|
13,858
|
||||||||||||
Comprehensive income
for the period
|
16,982
|
420
|
17,402
|
For the year ended December 31, 2024
|
||||||||||||||||
US GAAP
|
Adjustments
|
IFRS
|
||||||||||||||
In USD thousand
|
In USD thousand
|
In USD thousand
|
||||||||||||||
Revenues
|
234,641
|
(835
|
)
|
233,806
|
||||||||||||
Operating expenses
|
A |
185,058
|
(6,050
|
)
|
179,008
|
|||||||||||
Depreciation and amortization
|
A |
18,721
|
1,381
|
20,102
|
||||||||||||
Operating profit
|
30,862
|
3,834
|
34,696
|
|||||||||||||
Finance expenses
|
B,F |
23,513
|
(18
|
)
|
23,495
|
|||||||||||
Profit for the year
|
7,349
|
3,852
|
11,201
|
|||||||||||||
Other comprehensive income
|
B |
19,340
|
817
|
20,157
|
||||||||||||
Comprehensive income for the year
|
26,689
|
4,669
|
31,358
|
For the six-month period ended June 30, 2025
|
||||||||||||||||
US GAAP
|
Adjustments
|
IFRS
|
||||||||||||||
In USD thousand
|
In USD thousand
|
In USD thousand
|
||||||||||||||
Profit for the period
|
A,B |
24,520
|
4,619
|
29,139
|
||||||||||||
Net cash provided by operating activities
|
33,096
|
-
|
33,096
|
|||||||||||||
Net cash provided by (used for) investing activities
|
D |
(1,056
|
)
|
1,623
|
567
|
|||||||||||
Net cash used for financing activities
|
(34,007
|
)
|
-
|
(34,007
|
)
|
|||||||||||
Net decrease in cash and cash equivalents
|
(1,967
|
)
|
1,623
|
(344
|
)
|
|||||||||||
Balance of cash and cash equivalents as of the beginning of the period
|
D |
34
|
4,800
|
4,834
|
||||||||||||
Restricted cash balance as of the beginning of the period
|
D |
29,040
|
(29,040
|
)
|
-
|
|||||||||||
Balance of cash and cash equivalents as of the end of the period
|
D |
44
|
4,446
|
4,490
|
||||||||||||
Restricted cash balance as of the end of the period
|
D |
27,063
|
(27,063
|
)
|
-
|
For the six-month period ended June 30, 2024
|
||||||||||||||||
US GAAP
|
Adjustments
|
IFRS
|
||||||||||||||
In USD thousand
|
In USD thousand
|
In USD thousand
|
||||||||||||||
Profit for the period
|
A,B |
1,420
|
463
|
1,883
|
||||||||||||
Net cash provided by operating activities
|
2,553
|
-
|
2,553
|
|||||||||||||
Net cash used for investing activities
|
D |
(7,482
|
)
|
(802
|
)
|
(8,284
|
)
|
|||||||||
Net cash provided by financing activities
|
2,288
|
-
|
2,288
|
|||||||||||||
Net decrease in cash and cash equivalents
|
(2,641
|
)
|
(802
|
)
|
(3,443
|
)
|
||||||||||
Balance of cash and cash equivalents as of the beginning of the period
|
D |
41
|
4,341
|
4,382
|
||||||||||||
Restricted cash balance as of the beginning of the period
|
D |
28,917
|
(28,917
|
)
|
-
|
|||||||||||
Balance of cash and cash equivalents as of the end of the period
|
D |
44
|
895
|
939
|
||||||||||||
Restricted cash balance as of the end of the period
|
D |
26,273
|
(26,273
|
)
|
-
|
For the three-month period ended June 30, 2025
|
||||||||||||||||
US GAAP
|
Adjustments
|
IFRS
|
||||||||||||||
In USD thousand
|
In USD thousand
|
In USD thousand
|
||||||||||||||
Profit for the period
|
A,B |
15,162
|
686
|
15,848
|
||||||||||||
Net cash provided by operating activities
|
19,329
|
-
|
19,329
|
|||||||||||||
Net cash used for investing activities
|
D |
(554
|
)
|
532
|
(22
|
)
|
||||||||||
Net cash used for financing activities
|
(19,232
|
)
|
-
|
(19,232
|
)
|
|||||||||||
Net increase (decrease) in cash and cash equivalents
|
(457
|
)
|
532
|
75
|
||||||||||||
Balance of cash and cash equivalents as of the beginning of the period
|
D |
44
|
4,371
|
4,415
|
||||||||||||
Restricted cash balance as of the beginning of the period
|
D |
27,520
|
(27,520
|
)
|
-
|
|||||||||||
Balance of cash and cash equivalents as of the end of the period
|
D |
44
|
4,446
|
4,490
|
||||||||||||
Restricted cash balance as of the end of the period
|
D |
27,063
|
(27,063)
|
)
|
-
|
For the three-month period ended June 30, 2024
|
||||||||||||||||
US GAAP
|
Adjustments
|
IFRS
|
||||||||||||||
In USD thousand
|
In USD thousand
|
In USD thousand
|
||||||||||||||
Profit for the period
|
A,B |
3,284
|
260
|
3,544
|
||||||||||||
Net cash provided by operating activities
|
1,391
|
-
|
1,391
|
|||||||||||||
Net cash used for investing activities
|
D |
(572
|
)
|
201
|
(371
|
)
|
||||||||||
Net cash used from financing activities
|
(4,334
|
)
|
-
|
(4,334
|
)
|
|||||||||||
Net decrease in cash and cash equivalents
|
(3,515
|
)
|
201
|
(3,314
|
)
|
|||||||||||
Balance of cash and cash equivalents as of the beginning of the period
|
D |
50
|
4,203
|
4,253
|
||||||||||||
Restricted cash balance as of the beginning of the period
|
D |
29,782
|
(29,782
|
)
|
-
|
|||||||||||
Balance of cash and cash equivalents as of the end of the period
|
D |
44
|
895
|
939
|
||||||||||||
Restricted cash balance as of the end of the period
|
D |
26,273
|
(26,273)
|
)
|
-
|
For the year ended December 31, 2024
|
||||||||||||||||
US GAAP
|
Adjustments
|
IFRS
|
||||||||||||||
In USD thousand
|
In USD thousand
|
In USD thousand
|
||||||||||||||
Profit for the year
|
A,B |
7,349
|
3,852
|
11,201
|
||||||||||||
Net cash provided by operating activities
|
22,178
|
-
|
22,178
|
|||||||||||||
Net cash used for investing activities
|
D |
(8,882
|
)
|
336
|
(8,546
|
)
|
||||||||||
Net cash used for financing activities
|
(13,180
|
)
|
-
|
(13,180
|
)
|
|||||||||||
Net increase in cash and cash equivalents
|
116
|
336
|
452
|
|||||||||||||
Balance of cash and cash equivalents as of the beginning of the year
|
D |
41
|
4,341
|
4,382
|
||||||||||||
Restricted cash balance as of the beginning of the year
|
D |
28,917
|
(28,917
|
)
|
-
|
|||||||||||
Balance of cash and cash equivalents as of the end of the year
|
D |
34
|
4,800
|
4,834
|
||||||||||||
Restricted cash balance as of the end of the year
|
D |
|
29,040
|
(29,040
|
)
|
-
|
A. |
Maintenance costs under the Long Term Maintenance Plan (hereinafter – the “LTPC Agreement”): under IFRS, variable payments which were paid in accordance with the milestones as set in the LTPC
Agreement are capitalized to the cost of property, plant and equipment and amortized over the period from the date on which maintenance work was carried out until the date on which maintenance work is due to take place again. Under US
GAAP, the said payments are recognized on payment date within current expenses in the statement of income.
|
B. |
Hedge effectiveness of swaps: in accordance with the IFRS – the associates recognize adjustments relating to the ineffective portion of their cash flow hedge under profit and loss. Under US GAAP, there is no part which is not
effective, and the hedging results are recognized in full in other comprehensive income.
|
C. |
Intangible assets: Under IFRS, certain intangible assets are defined as property, plant and equipment.
|
D. |
Restricted cash: There is a difference between the presentation and classification of restricted cash in the cash flow statements and in the statements of financial position.
|
E. |
Right-of-use assets: In IFRS, certain contracts are classified as leases. Under US GAAP, these contracts do not meet the
definition of lease contracts and are recorded as operating expenses.
|
F. |
Changes in financing and refinancing agreements: In cases where the Group has made a change in conditions of existing loans and the change is immaterial, in accordance with IFRS 9, the carrying value of the loans has been adjusted to
reflect the present value of the updated contractual cash flows, discounted according to the original effective interest rate. The difference resulting from this adjustment was immediately recognized in the income statement. Under US
GAAP, there was no effect on profit or loss date on which the terms and conditions were changed.
|